MedPath

Sahlgrenska Cardiomyopathy Project

Conditions
Myocarditis
Dilated Cardiomyopathies
Restrictive Cardiomyopathy
Sarcoidosis With Myocarditis
Giant Cell Myocarditis
Arrhythmogenic Right Ventricular Cardiomyopathy
Amyloidosis; Heart (Manifestation)
Hypertrophic Cardiomyopathy
Registration Number
NCT03527342
Lead Sponsor
Göteborg University
Brief Summary

This is a joint project by Sahlgrenska University Hospital: Sahlgrenska, Östra and Mölndal.

Our objective is to diagnose and map patients with well phenotyped cardiomyopathies (CMP) including in depth clinical and molecular phenotyping to enable earlier and specific treatment. The project will serve as:

1. resource for diagnostic and therapeutic trials

2. common biomaterial bank

3. resource for detailed molecular analyses on patients' biomaterials and patient specific symptoms and examination results

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • Patients with primary cardiomyopathies including hereditary and inflammatory dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, left ventricular non-compaction cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, myocarditis, giant cell myocarditis, sarcoidosis and amyloidosis engaging the heart
Exclusion Criteria
  • Patient with other preexisting cardiac diseases such as significant valvular, ischemic or pericardial disease before they receive a cardiomyopathy diagnose
  • patients < 18 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to disease progression2018-2028
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Göteborg University, Sahlgrenska Universitetssjukhuset

🇸🇪

Göteborg, Sweden

© Copyright 2025. All Rights Reserved by MedPath